216 related articles for article (PubMed ID: 28742793)
21. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
[TBL] [Abstract][Full Text] [Related]
22. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
23. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
24. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
[TBL] [Abstract][Full Text] [Related]
25. Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer.
Kim SL; Lee ST; Trang KT; Kim SH; Kim IH; Lee SO; Kim DG; Kim SW
Int J Mol Med; 2014 May; 33(5):1261-7. PubMed ID: 24573421
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases.
Lesslie DP; Summy JM; Parikh NU; Fan F; Trevino JG; Sawyer TK; Metcalf CA; Shakespeare WC; Hicklin DJ; Ellis LM; Gallick GE
Br J Cancer; 2006 Jun; 94(11):1710-7. PubMed ID: 16685275
[TBL] [Abstract][Full Text] [Related]
27. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K
Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048
[TBL] [Abstract][Full Text] [Related]
28. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.
Li Y; Dong M; Kong F; Zhou J
Tumour Biol; 2015 Dec; 36(12):9941-6. PubMed ID: 26178483
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
Nasir A; Reising LO; Nedderman DM; Fulford AD; Uhlik MT; Benjamin LE; Schade AE; Holzer TR
Anticancer Res; 2016 Jun; 36(6):2683-96. PubMed ID: 27272777
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
[TBL] [Abstract][Full Text] [Related]
31. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
32. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
[TBL] [Abstract][Full Text] [Related]
33. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
34. Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism.
Ahluwalia A; Jones MK; Szabo S; Tarnawski AS
Biochem Biophys Res Commun; 2013 Aug; 437(4):515-20. PubMed ID: 23831629
[TBL] [Abstract][Full Text] [Related]
35. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
36. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
38. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells.
Sulpice E; Ding S; Muscatelli-Groux B; Bergé M; Han ZC; Plouet J; Tobelem G; Merkulova-Rainon T
Biol Cell; 2009 Sep; 101(9):525-39. PubMed ID: 19281453
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
40. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
